This study aimed to explore the post-acute impact on non-hospitalized Danish patients 2-6 months after being infected with SARS-CoV-2 by looking into incident drug use, overall healthcare, and hospital diagnoses. Eligible participants were those with a negative or positive RT-PCR test from February 27-May 31, 2020 in Denmark. Results show that 85.6% (8983) of the 10,498 eligible participants who tested positive were alive and not admitted to the hospital 2 weeks after their test while 1,310 participants were admitted two weeks after their test. 30.7% (2757) of the 8983 participants began new drug treatments compared to the 35.3% of participants who tested negative. Participants who tested positive (1.8%) were more likely to take bronchodilation drugs than those who tested negative (1.5%). After comparing positive vs negative participants, researchers found no increased risk of severe acute complications; however, the increased visit for COVID-19 positive patients to their primary-care physicians, may indicate the management of long-covid symptoms.